Home
/
Sanara MedTech Inc.
/
Financials
/
Quarterly
Sanara MedTech Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Sanara MedTech Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2021
Sep 30, 2021
$5.82M
Nov 12, 2021
Q2
2021
Jun 30, 2021
$6.28M
Aug 16, 2021
Q1
2021
Mar 31, 2021
$5.01M
May 14, 2021
Q2
2021
Mar 31, 2021
$11.29M
Aug 16, 2021
Q3
2021
Sep 30, 2020
$4.31M
Nov 12, 2021
Q2
2021
Jun 30, 2020
$2.97M
Aug 16, 2021
Q2
2021
Mar 31, 2020
$6.49M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$3.52M
May 14, 2021
Q3
2020
Sep 30, 2019
$2.91M
Nov 13, 2020
Q2
2020
Jun 30, 2019
$3.02M
Aug 13, 2020
Q1
2020
Mar 31, 2019
$2.49M
May 12, 2020
Q3
2018
Sep 30, 2018
$1.57M
Nov 14, 2018
Q2
2019
Jun 30, 2018
$2.26M
Aug 14, 2019
Q1
2019
Mar 31, 2018
$1.96M
May 20, 2019
Q3
2018
Sep 30, 2017
$1.55M
Nov 14, 2018
Q2
2018
Jun 30, 2017
$1.45M
Aug 13, 2018
Q1
2018
Mar 31, 2017
$1.61M
May 15, 2018
Q3
2017
Sep 30, 2016
$1.41M
Nov 16, 2017
Q2
2017
Jun 30, 2016
$1.26M
Aug 14, 2017
Q1
2017
Mar 31, 2016
$1.10M
May 15, 2017
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$26.33M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$25.83M
Aug 13, 2025
Q1
2025
Mar 31, 2025
$23.43M
May 14, 2025
Q3
2025
Sep 30, 2024
$21.67M
Nov 12, 2025
Q2
2025
Jun 30, 2024
$20.16M
Aug 13, 2025
Q1
2025
Mar 31, 2024
$18.54M
May 14, 2025
Q3
2024
Sep 30, 2023
$16.02M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$15.75M
Aug 12, 2024
Q1
2024
Mar 31, 2023
$15.52M
May 13, 2024
Q3
2023
Sep 30, 2022
$13.04M
Nov 13, 2023
Q2
2023
Jun 30, 2022
$9.67M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$7.81M
May 15, 2023
Q3
2022
Sep 30, 2021
$5.82M
Nov 14, 2022
Q2
2022
Jun 30, 2021
$6.28M
Aug 15, 2022
Q1
2022
Mar 31, 2021
$5.01M
May 16, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($30.41M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($2.01M)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($3.53M)
May 14, 2025
Q3
2025
Sep 30, 2024
($2.86M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.50M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($1.76M)
May 14, 2025
Q3
2024
Sep 30, 2023
($1.06M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.83M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($1.18M)
May 13, 2024
Q3
2023
Sep 30, 2022
($1.47M)
Nov 13, 2023
Q3
2022
Jun 30, 2022
$756.9K
Nov 14, 2022
Q2
2023
Jun 30, 2022
$769.4K
Aug 14, 2023
Q2
2022
Mar 31, 2022
($3.16M)
Aug 15, 2022
Q3
2022
Mar 31, 2022
($3.16M)
Nov 14, 2022
Q1
2023
Mar 31, 2022
($3.13M)
May 15, 2023
Q3
2022
Sep 30, 2021
($2.05M)
Nov 14, 2022
Q3
2022
Jun 30, 2021
($1.21M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.21M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.18M)
May 16, 2022
Q2
2022
Mar 31, 2021
($1.18M)
Aug 15, 2022
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.94M
Nov 12, 2025
Q2
2025
Jun 30, 2025
($31.3K)
Aug 13, 2025
Q1
2025
Mar 31, 2025
($2.08M)
May 14, 2025
Q3
2025
Sep 30, 2024
$778.5K
Nov 12, 2025
Q2
2025
Jun 30, 2024
($2.88M)
Aug 13, 2025
Q1
2025
Mar 31, 2024
($1.53M)
May 14, 2025
Q3
2024
Sep 30, 2023
($906.7K)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.87M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($1.22M)
May 13, 2024
Q3
2023
Sep 30, 2022
($3.23M)
Nov 13, 2023
Q3
2022
Jun 30, 2022
($3.32M)
Nov 14, 2022
Q2
2023
Jun 30, 2022
($3.38M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($2.78M)
May 15, 2023
Q3
2022
Sep 30, 2021
($1.85M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($1.03M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.08M)
May 16, 2022
Q3
2021
Sep 30, 2020
($1.31M)
Nov 12, 2021
Q2
2021
Jun 30, 2020
($1.08M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($1.80M)
May 14, 2021
Q3
2020
Sep 30, 2019
($797.2K)
Nov 13, 2020